CDx Diagnostics Inc. products

A routine diagnostic test that empowers doctors to help prevent oral cancer and save lives. OralCDx allows you to painlessly test any white or red spot in the mouth to rule out the possibility that precancerous cells are present. If dysplasia is found, the cells can typically be removed in order to stop the progression of oral cancer.

Provides physicians with a practical method of testing non-suspicious tissue in order to help prevent laryngeal cancer. Otolaryngologists are often faced with a dilemma when relatively non-suspicious tissue is observed in the office during flexible laryngoscopy. The probability that commonly observed tissue abnormalities are dysplastic is low, while a forceps biopsy to test these lesions presents unavoidable risks and costs. For this reason, forceps biopsy has generally been reserved for those lesions which appear relatively suspicious. Unfortunately, by the time a lesion appears clinically suspicious, it may have already progressed to a more advanced and less easily treatable stage.

AI-powered diagnostic platform to help prevent esophageal cancer. Included in the Standard of Practice Guidelines for the screening and surveillance of Barrett’s esophagus, WATS3D is our proprietary diagnostic platform for identifying precancerous cells in the esophagus.